Life Healthcare expects FY2026 normalized EPS from continuing operations to rise 6%-11%

PUBT · 3d ago
Life Healthcare expects FY2026 normalized EPS from continuing operations to rise 6%-11%
  • Life Healthcare expects normalized EPS from continuing operations of 106.3–111.3 cents for the year ended September 30, 2026, up 6%–11%.
  • Total EPS is forecast to fall 63%–68% to 84.2–97.3 cents, reflecting the prior year's Life Molecular Imaging disposal.
  • The FY2025 disposal generated a R 2.4 billion net gain, distorting earnings comparisons.
  • Total headline EPS is expected at 96–100.5 cents, up 8%–13% against the pro forma comparison.
  • Full-year results are expected on or about November 26, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Life Healthcare Group Holdings Limited published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S606515), on November 12, 2026, and is solely responsible for the information contained therein.